KORNMAN KENNETH S 4
4 · INTERLEUKIN GENETICS INC · Filed Apr 8, 2010
Insider Transaction Report
Form 4
KORNMAN KENNETH S
DirectorChief Scientific Officer/Pres.
Transactions
- Award
Stock Option (Right to Buy)
2010-04-06+30,000→ 30,000 totalExercise: $0.74Exp: 2020-04-06→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The option vests over five years as to 20% of the shares on each of April 6, 2011, April 6, 2012, April 6, 2013, April 6, 2014, and April 6, 2015.
- [F2]The exercise price of the option is the closing price of the Issuer's common stock on the NYSE Amex on 04/05/2010, which was the trading day immediately prior to the grant date of the option.